Selected Cell
Cell:
Value:
Pcitri.ignored_ids.dumb.final.p
Sheet3
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
20401
20402
20403
20404
20405
20406
20407
20408
20409
20410
20411
20412
20413
20414
20415
20416
20417
20418
20419
20420
20421
20422
20423
20424
20425
20426
20427
20428
20429
20430
20431
20432
20433
20434
20435
20436
20437
20438
20439
20440
20441
20442
20443
20444
20445
20446
20447
20448
20449
20450
20451
20452
20453
20454
20455
20456
20457
20458
20459
20460
20461
20462
20463
20464
20465
20466
20467
20468
20469
20470
20471
20472
20473
20474
20475
20476
20477
20478
20479
20480
20481
20482
20483
20484
20485
20486
20487
20488
20489
20490
20491
20492
20493
20494
20495
20496
20497
20498
20499
20500
20501
20502
20503
20504
20505
20506
20507
20508
20509
20510
20511
20512
20513
20514
20515
20516
20517
20518
20519
20520
20521
20522
20523
20524
20525
20526
20527
20528
20529
20530
20531
20532
20533
20534
20535
20536
20537
20538
20539
20540
20541
20542
20543
20544
20545
20546
20547
20548
20549
20550
20551
20552
20553
20554
20555
20556
20557
20558
20559
20560
20561
20562
20563
20564
20565
20566
20567
20568
20569
20570
20571
20572
20573
20574
20575
20576
20577
20578
20579
20580
20581
20582
20583
20584
20585
20586
20587
20588
20589
20590
20591
20592
20593
20594
20595
20596
20597
20598
20599
20600
| UnnamedSample_HQ_transcript/12937|m.4800 | UnnamedSample_HQ_transcript/12937 | Identity 0.837 too low. | 76e8f45586c0c7ae378e581bfa288cf2 | 339 | Pfam | PF00010 | Helix-loop-helix DNA-binding domain | 34 | 91 | 1.2E-14 | T | 22-09-2020 | IPR011598 | Myc-type, basic helix-loop-helix (bHLH) domain |
| UnnamedSample_HQ_transcript/12937|m.4800 | UnnamedSample_HQ_transcript/12937 | Identity 0.837 too low. | 76e8f45586c0c7ae378e581bfa288cf2 | 339 | Pfam | PF07527 | Hairy Orange | 108 | 143 | 2.2E-9 | T | 22-09-2020 | IPR003650 | Orange domain |
| UnnamedSample_HQ_transcript/42184|m.12307 | UnnamedSample_HQ_transcript/42184 | Coverage 0.982 too low. | 76e8f45586c0c7ae378e581bfa288cf2 | 339 | Pfam | PF00010 | Helix-loop-helix DNA-binding domain | 34 | 91 | 1.2E-14 | T | 22-09-2020 | IPR011598 | Myc-type, basic helix-loop-helix (bHLH) domain |
| UnnamedSample_HQ_transcript/42184|m.12307 | UnnamedSample_HQ_transcript/42184 | Coverage 0.982 too low. | 76e8f45586c0c7ae378e581bfa288cf2 | 339 | Pfam | PF07527 | Hairy Orange | 108 | 143 | 2.2E-9 | T | 22-09-2020 | IPR003650 | Orange domain |
| UnnamedSample_HQ_transcript/90502|m.21329 | UnnamedSample_HQ_transcript/90502 | Coverage 0.265 too low. | 2c57a6c9b545b259141026ae835a3816 | 367 | Pfam | PF00201 | UDP-glucoronosyl and UDP-glucosyl transferase | 12 | 345 | 2.0E-93 | T | 22-09-2020 | IPR002213 | UDP-glucuronosyl/UDP-glucosyltransferase |
| UnnamedSample_HQ_transcript/14651|m.5309 | UnnamedSample_HQ_transcript/14651 | Coverage 0.874 too low. | d7ab5aba00f46524ea88369d8cf4cab1 | 1046 | Pfam | PF01590 | GAF domain | 447 | 536 | 2.3E-12 | T | 22-09-2020 | IPR003018 | GAF domain |
| UnnamedSample_HQ_transcript/14651|m.5309 | UnnamedSample_HQ_transcript/14651 | Coverage 0.874 too low. | d7ab5aba00f46524ea88369d8cf4cab1 | 1046 | Pfam | PF01590 | GAF domain | 574 | 719 | 8.8E-15 | T | 22-09-2020 | IPR003018 | GAF domain |
| UnnamedSample_HQ_transcript/14651|m.5309 | UnnamedSample_HQ_transcript/14651 | Coverage 0.874 too low. | d7ab5aba00f46524ea88369d8cf4cab1 | 1046 | Pfam | PF00233 | 3'5'-cyclic nucleotide phosphodiesterase | 825 | 1033 | 4.1E-64 | T | 22-09-2020 | IPR002073 | 3'5'-cyclic nucleotide phosphodiesterase, catalytic domain |
| UnnamedSample_HQ_transcript/41881|m.12238 | UnnamedSample_HQ_transcript/41881 | Identity 0.891 too low. | d60a4e995332d5947bbbb6febd41691b | 368 | Pfam | PF02879 | Phosphoglucomutase/phosphomannomutase, alpha/beta/alpha domain II | 10 | 103 | 1.3E-16 | T | 22-09-2020 | IPR005845 | Alpha-D-phosphohexomutase, alpha/beta/alpha domain II |
| UnnamedSample_HQ_transcript/41881|m.12238 | UnnamedSample_HQ_transcript/41881 | Identity 0.891 too low. | d60a4e995332d5947bbbb6febd41691b | 368 | Pfam | PF02880 | Phosphoglucomutase/phosphomannomutase, alpha/beta/alpha domain III | 113 | 226 | 9.4E-29 | T | 22-09-2020 | IPR005846 | Alpha-D-phosphohexomutase, alpha/beta/alpha domain III |
| UnnamedSample_HQ_transcript/41881|m.12238 | UnnamedSample_HQ_transcript/41881 | Identity 0.891 too low. | d60a4e995332d5947bbbb6febd41691b | 368 | Pfam | PF00408 | Phosphoglucomutase/phosphomannomutase, C-terminal domain | 276 | 342 | 4.3E-7 | T | 22-09-2020 | IPR005843 | Alpha-D-phosphohexomutase, C-terminal |
| UnnamedSample_HQ_transcript/7181|m.2919 | UnnamedSample_HQ_transcript/7181 | Coverage 0.885 too low. | efac2c2b3ae9ba72f1838b59905f012c | 515 | Pfam | PF07714 | Protein tyrosine and serine/threonine kinase | 95 | 345 | 1.8E-50 | T | 22-09-2020 | IPR001245 | Serine-threonine/tyrosine-protein kinase, catalytic domain |
| UnnamedSample_HQ_transcript/17219|m.6072 | UnnamedSample_HQ_transcript/17219 | Identity 0.890 too low. | 50c7ebfc2149c94b7d53b090d3fc3c48 | 382 | Pfam | PF00017 | SH2 domain | 225 | 303 | 5.4E-10 | T | 22-09-2020 | IPR000980 | SH2 domain |
| UnnamedSample_HQ_transcript/17219|m.6072 | UnnamedSample_HQ_transcript/17219 | Identity 0.890 too low. | 50c7ebfc2149c94b7d53b090d3fc3c48 | 382 | Pfam | PF02864 | STAT protein, DNA binding domain | 1 | 105 | 2.6E-29 | T | 22-09-2020 | IPR013801 | STAT transcription factor, DNA-binding |
| UnnamedSample_HQ_transcript/88102|m.20954 | UnnamedSample_HQ_transcript/88102 | Coverage 0.684 too low. | 13ae53388bd2895b38e0ba0b08ae94a0 | 426 | Pfam | PF00201 | UDP-glucoronosyl and UDP-glucosyl transferase | 132 | 426 | 4.9E-56 | T | 22-09-2020 | IPR002213 | UDP-glucuronosyl/UDP-glucosyltransferase |
| UnnamedSample_HQ_transcript/111736|m.24046 | UnnamedSample_HQ_transcript/111736 | Coverage 0.965 too low. | 623a5cc6b3e038f0084023feb667452a | 191 | Pfam | PF02230 | Phospholipase/Carboxylesterase | 2 | 127 | 6.5E-17 | T | 22-09-2020 | IPR003140 | Phospholipase/carboxylesterase/thioesterase |
| UnnamedSample_HQ_transcript/89514|m.21164 | UnnamedSample_HQ_transcript/89514 | Coverage 0.564 too low. | a49bfbb156b37e20e383e077bd04d2cc | 346 | Pfam | PF00240 | Ubiquitin family | 79 | 150 | 1.2E-33 | T | 22-09-2020 | IPR000626 | Ubiquitin-like domain |
| UnnamedSample_HQ_transcript/89514|m.21164 | UnnamedSample_HQ_transcript/89514 | Coverage 0.564 too low. | a49bfbb156b37e20e383e077bd04d2cc | 346 | Pfam | PF00240 | Ubiquitin family | 167 | 191 | 4.4E-6 | T | 22-09-2020 | IPR000626 | Ubiquitin-like domain |
| UnnamedSample_HQ_transcript/89514|m.21164 | UnnamedSample_HQ_transcript/89514 | Coverage 0.564 too low. | a49bfbb156b37e20e383e077bd04d2cc | 346 | Pfam | PF00240 | Ubiquitin family | 196 | 267 | 1.2E-33 | T | 22-09-2020 | IPR000626 | Ubiquitin-like domain |
| UnnamedSample_HQ_transcript/89514|m.21164 | UnnamedSample_HQ_transcript/89514 | Coverage 0.564 too low. | a49bfbb156b37e20e383e077bd04d2cc | 346 | Pfam | PF00240 | Ubiquitin family | 3 | 74 | 1.2E-33 | T | 22-09-2020 | IPR000626 | Ubiquitin-like domain |
| UnnamedSample_HQ_transcript/89514|m.21164 | UnnamedSample_HQ_transcript/89514 | Coverage 0.564 too low. | a49bfbb156b37e20e383e077bd04d2cc | 346 | Pfam | PF00240 | Ubiquitin family | 272 | 343 | 1.2E-33 | T | 22-09-2020 | IPR000626 | Ubiquitin-like domain |
| UnnamedSample_HQ_transcript/29520|m.9360 | UnnamedSample_HQ_transcript/29520 | Coverage 0.216 too low. | bfe14eb43badd9302f56e271b306fdc1 | 665 | Pfam | PF08373 | RAP domain | 597 | 643 | 6.7E-8 | T | 22-09-2020 | IPR013584 | RAP domain |
| UnnamedSample_HQ_transcript/44469|m.12811 | UnnamedSample_HQ_transcript/44469 | Coverage 0.035 too low. | bfe14eb43badd9302f56e271b306fdc1 | 665 | Pfam | PF08373 | RAP domain | 597 | 643 | 6.7E-8 | T | 22-09-2020 | IPR013584 | RAP domain |
| UnnamedSample_HQ_transcript/43168|m.12525 | UnnamedSample_HQ_transcript/43168 | Coverage 0.685 too low. | d882b6b4f0c552c04aee64007da1471b | 357 | Pfam | PF00001 | 7 transmembrane receptor (rhodopsin family) | 61 | 323 | 4.3E-52 | T | 22-09-2020 | IPR017452 | GPCR, rhodopsin-like, 7TM |
| UnnamedSample_HQ_transcript/5985|m.2538 | UnnamedSample_HQ_transcript/5985 | Coverage 0.454 too low. | 5845c92dc676f48296cf6084cd1b09bf | 460 | Pfam | PF00169 | PH domain | 56 | 155 | 1.3E-6 | T | 22-09-2020 | IPR001849 | Pleckstrin homology domain |
| UnnamedSample_HQ_transcript/5985|m.2538 | UnnamedSample_HQ_transcript/5985 | Coverage 0.454 too low. | 5845c92dc676f48296cf6084cd1b09bf | 460 | Pfam | PF00620 | RhoGAP domain | 283 | 433 | 7.0E-40 | T | 22-09-2020 | IPR000198 | Rho GTPase-activating protein domain |
| UnnamedSample_HQ_transcript/25511|m.8345 | UnnamedSample_HQ_transcript/25511 | Coverage 0.113 too low. | 5bdf2d67f3e518391c7c379a0d23ab5e | 301 | Pfam | PF13927 | Immunoglobulin domain | 151 | 230 | 1.4E-10 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/25511|m.8345 | UnnamedSample_HQ_transcript/25511 | Coverage 0.113 too low. | 5bdf2d67f3e518391c7c379a0d23ab5e | 301 | Pfam | PF07679 | Immunoglobulin I-set domain | 47 | 130 | 4.9E-11 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/58911|m.15833 | UnnamedSample_HQ_transcript/58911 | Coverage 0.890 too low. | d43679390ea30e0f70ee0829c4e530c5 | 391 | Pfam | PF00069 | Protein kinase domain | 34 | 317 | 3.6E-67 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/35808|m.10884 | UnnamedSample_HQ_transcript/35808 | Coverage 0.990 too low. | d43679390ea30e0f70ee0829c4e530c5 | 391 | Pfam | PF00069 | Protein kinase domain | 34 | 317 | 3.6E-67 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/68237|m.17626 | UnnamedSample_HQ_transcript/68237 | Identity 0.892 too low. | d43679390ea30e0f70ee0829c4e530c5 | 391 | Pfam | PF00069 | Protein kinase domain | 34 | 317 | 3.6E-67 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/76105|m.19044 | UnnamedSample_HQ_transcript/76105 | Coverage 0.725 too low. | a064d7ee39be3c1850fcc3cd9c4e29be | 253 | Pfam | PF00250 | Forkhead domain | 1 | 69 | 1.5E-25 | T | 22-09-2020 | IPR001766 | Fork head domain |
| UnnamedSample_HQ_transcript/76105|m.19044 | UnnamedSample_HQ_transcript/76105 | Coverage 0.725 too low. | a064d7ee39be3c1850fcc3cd9c4e29be | 253 | Pfam | PF01090 | Ribosomal protein S19e | 117 | 231 | 2.6E-45 | T | 22-09-2020 | IPR001266 | Ribosomal protein S19e |
| UnnamedSample_HQ_transcript/28955|m.9216 | UnnamedSample_HQ_transcript/28955 | Coverage 0.798 too low. | 3f54364f4cc558ac8b3a8df514bc075e | 376 | Pfam | PF00554 | Rel homology DNA-binding domain | 174 | 333 | 1.7E-28 | T | 22-09-2020 | IPR011539 | Rel homology domain (RHD), DNA-binding domain |
| UnnamedSample_HQ_transcript/33591|m.10357 | UnnamedSample_HQ_transcript/33591 | Coverage 0.811 too low. | 964ef5ec6011448f9f5a207439d16597 | 500 | Pfam | PF01553 | Acyltransferase | 281 | 401 | 8.5E-18 | T | 22-09-2020 | IPR002123 | Phospholipid/glycerol acyltransferase |
| UnnamedSample_HQ_transcript/186|m.169 | UnnamedSample_HQ_transcript/186 | Coverage 0.838 too low. | c91e153557834924207bee9c61b8bd13 | 1739 | Pfam | PF12661 | Human growth factor-like EGF | 159 | 180 | 3.1E-4 | T | 22-09-2020 | IPR013032 | EGF-like, conserved site |
| UnnamedSample_HQ_transcript/186|m.169 | UnnamedSample_HQ_transcript/186 | Coverage 0.838 too low. | c91e153557834924207bee9c61b8bd13 | 1739 | Pfam | PF12661 | Human growth factor-like EGF | 1237 | 1258 | 1.4E-6 | T | 22-09-2020 | IPR013032 | EGF-like, conserved site |
| UnnamedSample_HQ_transcript/186|m.169 | UnnamedSample_HQ_transcript/186 | Coverage 0.838 too low. | c91e153557834924207bee9c61b8bd13 | 1739 | Pfam | PF12661 | Human growth factor-like EGF | 1315 | 1336 | 0.024 | T | 22-09-2020 | IPR013032 | EGF-like, conserved site |
| UnnamedSample_HQ_transcript/186|m.169 | UnnamedSample_HQ_transcript/186 | Coverage 0.838 too low. | c91e153557834924207bee9c61b8bd13 | 1739 | Pfam | PF07684 | NOTCH protein | 1618 | 1675 | 4.8E-16 | T | 22-09-2020 | IPR011656 | Notch, NODP domain |
| UnnamedSample_HQ_transcript/186|m.169 | UnnamedSample_HQ_transcript/186 | Coverage 0.838 too low. | c91e153557834924207bee9c61b8bd13 | 1739 | Pfam | PF00008 | EGF-like domain | 651 | 680 | 5.7E-9 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/186|m.169 | UnnamedSample_HQ_transcript/186 | Coverage 0.838 too low. | c91e153557834924207bee9c61b8bd13 | 1739 | Pfam | PF00008 | EGF-like domain | 803 | 833 | 7.5E-7 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/186|m.169 | UnnamedSample_HQ_transcript/186 | Coverage 0.838 too low. | c91e153557834924207bee9c61b8bd13 | 1739 | Pfam | PF00008 | EGF-like domain | 765 | 795 | 4.9E-8 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/186|m.169 | UnnamedSample_HQ_transcript/186 | Coverage 0.838 too low. | c91e153557834924207bee9c61b8bd13 | 1739 | Pfam | PF00008 | EGF-like domain | 383 | 413 | 1.4E-5 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/186|m.169 | UnnamedSample_HQ_transcript/186 | Coverage 0.838 too low. | c91e153557834924207bee9c61b8bd13 | 1739 | Pfam | PF00008 | EGF-like domain | 1071 | 1100 | 2.2E-8 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/186|m.169 | UnnamedSample_HQ_transcript/186 | Coverage 0.838 too low. | c91e153557834924207bee9c61b8bd13 | 1739 | Pfam | PF00008 | EGF-like domain | 1124 | 1148 | 1.3E-4 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/186|m.169 | UnnamedSample_HQ_transcript/186 | Coverage 0.838 too low. | c91e153557834924207bee9c61b8bd13 | 1739 | Pfam | PF00008 | EGF-like domain | 841 | 872 | 1.7E-4 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/186|m.169 | UnnamedSample_HQ_transcript/186 | Coverage 0.838 too low. | c91e153557834924207bee9c61b8bd13 | 1739 | Pfam | PF00008 | EGF-like domain | 268 | 298 | 4.0E-6 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/186|m.169 | UnnamedSample_HQ_transcript/186 | Coverage 0.838 too low. | c91e153557834924207bee9c61b8bd13 | 1739 | Pfam | PF00008 | EGF-like domain | 919 | 949 | 8.7E-8 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/186|m.169 | UnnamedSample_HQ_transcript/186 | Coverage 0.838 too low. | c91e153557834924207bee9c61b8bd13 | 1739 | Pfam | PF00008 | EGF-like domain | 229 | 259 | 3.3E-5 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/186|m.169 | UnnamedSample_HQ_transcript/186 | Coverage 0.838 too low. | c91e153557834924207bee9c61b8bd13 | 1739 | Pfam | PF00008 | EGF-like domain | 540 | 567 | 8.1E-7 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/186|m.169 | UnnamedSample_HQ_transcript/186 | Coverage 0.838 too low. | c91e153557834924207bee9c61b8bd13 | 1739 | Pfam | PF00008 | EGF-like domain | 1389 | 1419 | 5.5E-5 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/186|m.169 | UnnamedSample_HQ_transcript/186 | Coverage 0.838 too low. | c91e153557834924207bee9c61b8bd13 | 1739 | Pfam | PF00008 | EGF-like domain | 346 | 374 | 6.1E-5 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/186|m.169 | UnnamedSample_HQ_transcript/186 | Coverage 0.838 too low. | c91e153557834924207bee9c61b8bd13 | 1739 | Pfam | PF00008 | EGF-like domain | 116 | 147 | 1.5E-6 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/186|m.169 | UnnamedSample_HQ_transcript/186 | Coverage 0.838 too low. | c91e153557834924207bee9c61b8bd13 | 1739 | Pfam | PF00008 | EGF-like domain | 74 | 105 | 2.7E-5 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/186|m.169 | UnnamedSample_HQ_transcript/186 | Coverage 0.838 too low. | c91e153557834924207bee9c61b8bd13 | 1739 | Pfam | PF00008 | EGF-like domain | 727 | 757 | 1.5E-6 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/186|m.169 | UnnamedSample_HQ_transcript/186 | Coverage 0.838 too low. | c91e153557834924207bee9c61b8bd13 | 1739 | Pfam | PF00008 | EGF-like domain | 1033 | 1063 | 7.5E-9 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/186|m.169 | UnnamedSample_HQ_transcript/186 | Coverage 0.838 too low. | c91e153557834924207bee9c61b8bd13 | 1739 | Pfam | PF00008 | EGF-like domain | 1194 | 1222 | 2.1E-5 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/186|m.169 | UnnamedSample_HQ_transcript/186 | Coverage 0.838 too low. | c91e153557834924207bee9c61b8bd13 | 1739 | Pfam | PF00008 | EGF-like domain | 689 | 718 | 7.3E-7 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/186|m.169 | UnnamedSample_HQ_transcript/186 | Coverage 0.838 too low. | c91e153557834924207bee9c61b8bd13 | 1739 | Pfam | PF00008 | EGF-like domain | 576 | 604 | 3.0E-6 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/186|m.169 | UnnamedSample_HQ_transcript/186 | Coverage 0.838 too low. | c91e153557834924207bee9c61b8bd13 | 1739 | Pfam | PF00008 | EGF-like domain | 1156 | 1186 | 1.5E-7 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/186|m.169 | UnnamedSample_HQ_transcript/186 | Coverage 0.838 too low. | c91e153557834924207bee9c61b8bd13 | 1739 | Pfam | PF00008 | EGF-like domain | 957 | 987 | 1.1E-8 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/186|m.169 | UnnamedSample_HQ_transcript/186 | Coverage 0.838 too low. | c91e153557834924207bee9c61b8bd13 | 1739 | Pfam | PF00008 | EGF-like domain | 500 | 530 | 5.8E-8 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/186|m.169 | UnnamedSample_HQ_transcript/186 | Coverage 0.838 too low. | c91e153557834924207bee9c61b8bd13 | 1739 | Pfam | PF00008 | EGF-like domain | 613 | 643 | 7.6E-6 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/186|m.169 | UnnamedSample_HQ_transcript/186 | Coverage 0.838 too low. | c91e153557834924207bee9c61b8bd13 | 1739 | Pfam | PF00008 | EGF-like domain | 996 | 1025 | 1.5E-7 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/186|m.169 | UnnamedSample_HQ_transcript/186 | Coverage 0.838 too low. | c91e153557834924207bee9c61b8bd13 | 1739 | Pfam | PF00008 | EGF-like domain | 1270 | 1301 | 2.9E-6 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/186|m.169 | UnnamedSample_HQ_transcript/186 | Coverage 0.838 too low. | c91e153557834924207bee9c61b8bd13 | 1739 | Pfam | PF00066 | LNR domain | 1519 | 1552 | 7.2E-10 | T | 22-09-2020 | IPR000800 | Notch domain |
| UnnamedSample_HQ_transcript/186|m.169 | UnnamedSample_HQ_transcript/186 | Coverage 0.838 too low. | c91e153557834924207bee9c61b8bd13 | 1739 | Pfam | PF00066 | LNR domain | 1478 | 1514 | 1.4E-11 | T | 22-09-2020 | IPR000800 | Notch domain |
| UnnamedSample_HQ_transcript/186|m.169 | UnnamedSample_HQ_transcript/186 | Coverage 0.838 too low. | c91e153557834924207bee9c61b8bd13 | 1739 | Pfam | PF00066 | LNR domain | 1440 | 1472 | 9.9E-9 | T | 22-09-2020 | IPR000800 | Notch domain |
| UnnamedSample_HQ_transcript/186|m.169 | UnnamedSample_HQ_transcript/186 | Coverage 0.838 too low. | c91e153557834924207bee9c61b8bd13 | 1739 | Pfam | PF06816 | NOTCH protein | 1556 | 1609 | 6.7E-18 | T | 22-09-2020 | IPR010660 | Notch, NOD domain |
| UnnamedSample_HQ_transcript/186|m.169 | UnnamedSample_HQ_transcript/186 | Coverage 0.838 too low. | c91e153557834924207bee9c61b8bd13 | 1739 | Pfam | PF07645 | Calcium-binding EGF domain | 419 | 451 | 4.8E-8 | T | 22-09-2020 | IPR001881 | EGF-like calcium-binding domain |
| UnnamedSample_HQ_transcript/186|m.169 | UnnamedSample_HQ_transcript/186 | Coverage 0.838 too low. | c91e153557834924207bee9c61b8bd13 | 1739 | Pfam | PF07645 | Calcium-binding EGF domain | 459 | 492 | 1.1E-5 | T | 22-09-2020 | IPR001881 | EGF-like calcium-binding domain |
| UnnamedSample_HQ_transcript/186|m.169 | UnnamedSample_HQ_transcript/186 | Coverage 0.838 too low. | c91e153557834924207bee9c61b8bd13 | 1739 | Pfam | PF07645 | Calcium-binding EGF domain | 302 | 335 | 1.6E-8 | T | 22-09-2020 | IPR001881 | EGF-like calcium-binding domain |
| UnnamedSample_HQ_transcript/186|m.169 | UnnamedSample_HQ_transcript/186 | Coverage 0.838 too low. | c91e153557834924207bee9c61b8bd13 | 1739 | Pfam | PF07645 | Calcium-binding EGF domain | 877 | 912 | 5.8E-7 | T | 22-09-2020 | IPR001881 | EGF-like calcium-binding domain |
| UnnamedSample_HQ_transcript/186|m.169 | UnnamedSample_HQ_transcript/186 | Coverage 0.838 too low. | c91e153557834924207bee9c61b8bd13 | 1739 | Pfam | PF07645 | Calcium-binding EGF domain | 188 | 222 | 2.1E-5 | T | 22-09-2020 | IPR001881 | EGF-like calcium-binding domain |
| UnnamedSample_HQ_transcript/36906|m.11145 | UnnamedSample_HQ_transcript/36906 | Coverage 0.461 too low. | bcbf0057bfa432162014a267fc440de0 | 541 | Pfam | PF01130 | CD36 family | 17 | 463 | 4.6E-131 | T | 22-09-2020 | IPR002159 | CD36 family |
| UnnamedSample_HQ_transcript/75708|m.18970 | UnnamedSample_HQ_transcript/75708 | Coverage 0.071 too low. | e1ef95fcc77842ab098d3ef74e97731f | 491 | Pfam | PF08662 | Eukaryotic translation initiation factor eIF2A | 213 | 408 | 3.9E-78 | T | 22-09-2020 | IPR013979 | Translation initiation factor, beta propellor-like domain |
| UnnamedSample_HQ_transcript/86012|m.20656 | UnnamedSample_HQ_transcript/86012 | Coverage 0.807 too low. | 14131bb60f8840b7fedb4e63dfe892de | 335 | Pfam | PF00651 | BTB/POZ domain | 23 | 124 | 2.4E-26 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/400|m.310 | UnnamedSample_HQ_transcript/400 | Coverage 0.590 too low. | cf178ddbb1137188d73039fea8369392 | 1180 | Pfam | PF00630 | Filamin/ABP280 repeat | 614 | 697 | 8.7E-16 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/400|m.310 | UnnamedSample_HQ_transcript/400 | Coverage 0.590 too low. | cf178ddbb1137188d73039fea8369392 | 1180 | Pfam | PF00630 | Filamin/ABP280 repeat | 418 | 510 | 4.0E-12 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/400|m.310 | UnnamedSample_HQ_transcript/400 | Coverage 0.590 too low. | cf178ddbb1137188d73039fea8369392 | 1180 | Pfam | PF00630 | Filamin/ABP280 repeat | 998 | 1084 | 4.6E-20 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/400|m.310 | UnnamedSample_HQ_transcript/400 | Coverage 0.590 too low. | cf178ddbb1137188d73039fea8369392 | 1180 | Pfam | PF00630 | Filamin/ABP280 repeat | 805 | 892 | 2.2E-14 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/400|m.310 | UnnamedSample_HQ_transcript/400 | Coverage 0.590 too low. | cf178ddbb1137188d73039fea8369392 | 1180 | Pfam | PF00630 | Filamin/ABP280 repeat | 900 | 990 | 1.1E-14 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/400|m.310 | UnnamedSample_HQ_transcript/400 | Coverage 0.590 too low. | cf178ddbb1137188d73039fea8369392 | 1180 | Pfam | PF00630 | Filamin/ABP280 repeat | 318 | 410 | 6.3E-16 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/400|m.310 | UnnamedSample_HQ_transcript/400 | Coverage 0.590 too low. | cf178ddbb1137188d73039fea8369392 | 1180 | Pfam | PF00630 | Filamin/ABP280 repeat | 517 | 607 | 4.1E-14 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/400|m.310 | UnnamedSample_HQ_transcript/400 | Coverage 0.590 too low. | cf178ddbb1137188d73039fea8369392 | 1180 | Pfam | PF00630 | Filamin/ABP280 repeat | 709 | 797 | 6.2E-15 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/400|m.310 | UnnamedSample_HQ_transcript/400 | Coverage 0.590 too low. | cf178ddbb1137188d73039fea8369392 | 1180 | Pfam | PF00630 | Filamin/ABP280 repeat | 1091 | 1156 | 1.8E-6 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/400|m.310 | UnnamedSample_HQ_transcript/400 | Coverage 0.590 too low. | cf178ddbb1137188d73039fea8369392 | 1180 | Pfam | PF00307 | Calponin homology (CH) domain | 207 | 304 | 4.5E-13 | T | 22-09-2020 | IPR001715 | Calponin homology domain |
| UnnamedSample_HQ_transcript/400|m.310 | UnnamedSample_HQ_transcript/400 | Coverage 0.590 too low. | cf178ddbb1137188d73039fea8369392 | 1180 | Pfam | PF00307 | Calponin homology (CH) domain | 81 | 184 | 2.3E-22 | T | 22-09-2020 | IPR001715 | Calponin homology domain |
| UnnamedSample_HQ_transcript/104616|m.23183 | UnnamedSample_HQ_transcript/104616 | Identity 0.827 too low. | 374d6e4208ffef21a0ec3717fe83189d | 260 | Pfam | PF00112 | Papain family cysteine protease | 143 | 247 | 1.7E-21 | T | 22-09-2020 | IPR000668 | Peptidase C1A, papain C-terminal |
| UnnamedSample_HQ_transcript/104616|m.23183 | UnnamedSample_HQ_transcript/104616 | Identity 0.827 too low. | 374d6e4208ffef21a0ec3717fe83189d | 260 | Pfam | PF08246 | Cathepsin propeptide inhibitor domain (I29) | 26 | 81 | 3.0E-15 | T | 22-09-2020 | IPR013201 | Cathepsin propeptide inhibitor domain (I29) |
| UnnamedSample_HQ_transcript/50674|m.14169 | UnnamedSample_HQ_transcript/50674 | Coverage 0.947 too low. | ddf4c2f0c96c07c37806993edf04f000 | 264 | Pfam | PF00689 | Cation transporting ATPase, C-terminus | 28 | 231 | 1.3E-43 | T | 22-09-2020 | IPR006068 | Cation-transporting P-type ATPase, C-terminal |
| UnnamedSample_HQ_transcript/17418|m.6129 | UnnamedSample_HQ_transcript/17418 | Coverage 0.980 too low. | a6f10c3cccca3d1d76c1d8fccc634469 | 1031 | Pfam | PF05193 | Peptidase M16 inactive domain | 203 | 374 | 1.6E-10 | T | 22-09-2020 | IPR007863 | Peptidase M16, C-terminal |
| UnnamedSample_HQ_transcript/17418|m.6129 | UnnamedSample_HQ_transcript/17418 | Coverage 0.980 too low. | a6f10c3cccca3d1d76c1d8fccc634469 | 1031 | Pfam | PF00675 | Insulinase (Peptidase family M16) | 58 | 138 | 4.7E-6 | T | 22-09-2020 | IPR011765 | Peptidase M16, N-terminal |
| UnnamedSample_HQ_transcript/12673|m.4719 | UnnamedSample_HQ_transcript/12673 | Identity 0.916 too low. | a6f10c3cccca3d1d76c1d8fccc634469 | 1031 | Pfam | PF05193 | Peptidase M16 inactive domain | 203 | 374 | 1.6E-10 | T | 22-09-2020 | IPR007863 | Peptidase M16, C-terminal |
| UnnamedSample_HQ_transcript/12673|m.4719 | UnnamedSample_HQ_transcript/12673 | Identity 0.916 too low. | a6f10c3cccca3d1d76c1d8fccc634469 | 1031 | Pfam | PF00675 | Insulinase (Peptidase family M16) | 58 | 138 | 4.7E-6 | T | 22-09-2020 | IPR011765 | Peptidase M16, N-terminal |
| UnnamedSample_HQ_transcript/39872|m.11824 | UnnamedSample_HQ_transcript/39872 | Coverage 0.269 too low. | 9676686e5b10cb3d8f66dae1c856584d | 445 | Pfam | PF00651 | BTB/POZ domain | 29 | 122 | 1.5E-24 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/98786|m.22467 | UnnamedSample_HQ_transcript/98786 | Coverage 0.990 too low. | e7c9996ad2061410eebb0f33cbbef078 | 301 | Pfam | PF02585 | GlcNAc-PI de-N-acetylase | 77 | 198 | 2.8E-22 | T | 22-09-2020 | IPR003737 | N-acetylglucosaminyl phosphatidylinositol deacetylase-related |
| UnnamedSample_HQ_transcript/48706|m.13741 | UnnamedSample_HQ_transcript/48706 | Coverage 0.751 too low. | 1bc6993cfc817b42b483573de27ca170 | 461 | Pfam | PF07690 | Major Facilitator Superfamily | 21 | 376 | 1.4E-25 | T | 22-09-2020 | IPR011701 | Major facilitator superfamily |
| UnnamedSample_HQ_transcript/896|m.587 | UnnamedSample_HQ_transcript/896 | Unmapped. | 8f623db6807c872893bfe0090605a01a | 1351 | Pfam | PF13086 | AAA domain | 1260 | 1325 | 8.7E-9 | T | 22-09-2020 | IPR041677 | DNA2/NAM7 helicase, helicase domain |
| UnnamedSample_HQ_transcript/896|m.587 | UnnamedSample_HQ_transcript/896 | Unmapped. | 8f623db6807c872893bfe0090605a01a | 1351 | Pfam | PF00680 | Viral RNA-dependent RNA polymerase | 491 | 859 | 2.1E-9 | T | 22-09-2020 | IPR001205 | RNA-directed RNA polymerase, C-terminal domain |
| UnnamedSample_HQ_transcript/15203|m.5465 | UnnamedSample_HQ_transcript/15203 | Identity 0.943 too low. | d6545dd699f27b3a68031ded9f4cf520 | 304 | Pfam | PF12605 | Casein kinase 1 gamma C terminal | 244 | 268 | 1.5E-9 | T | 22-09-2020 | IPR022247 | Casein kinase 1 gamma C-terminal |
| UnnamedSample_HQ_transcript/15203|m.5465 | UnnamedSample_HQ_transcript/15203 | Identity 0.943 too low. | d6545dd699f27b3a68031ded9f4cf520 | 304 | Pfam | PF00069 | Protein kinase domain | 11 | 143 | 1.9E-18 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/3537|m.1629 | UnnamedSample_HQ_transcript/3537 | Coverage 0.840 too low. | ef239bffd7ab947faf30fbe994e2bc31 | 1457 | Pfam | PF00400 | WD domain, G-beta repeat | 128 | 163 | 4.4E-4 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/3537|m.1629 | UnnamedSample_HQ_transcript/3537 | Coverage 0.840 too low. | ef239bffd7ab947faf30fbe994e2bc31 | 1457 | Pfam | PF00400 | WD domain, G-beta repeat | 688 | 725 | 6.8E-4 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/3537|m.1629 | UnnamedSample_HQ_transcript/3537 | Coverage 0.840 too low. | ef239bffd7ab947faf30fbe994e2bc31 | 1457 | Pfam | PF00400 | WD domain, G-beta repeat | 88 | 119 | 1.1E-5 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/34440|m.10590 | UnnamedSample_HQ_transcript/34440 | Coverage 0.985 too low. | a1adb5be3c5cb820446e4122414ace84 | 716 | Pfam | PF01426 | BAH domain | 496 | 619 | 4.3E-9 | T | 22-09-2020 | IPR001025 | Bromo adjacent homology (BAH) domain |
| UnnamedSample_HQ_transcript/34440|m.10590 | UnnamedSample_HQ_transcript/34440 | Coverage 0.985 too low. | a1adb5be3c5cb820446e4122414ace84 | 716 | Pfam | PF12047 | Cytosine specific DNA methyltransferase replication foci domain | 123 | 255 | 4.3E-26 | T | 22-09-2020 | IPR022702 | DNA (cytosine-5)-methyltransferase 1, replication foci domain |
| UnnamedSample_HQ_transcript/88233|m.20973 | UnnamedSample_HQ_transcript/88233 | Identity 0.941 too low. | 9726bea724517c1ba51865c1322c8482 | 209 | Pfam | PF00145 | C-5 cytosine-specific DNA methylase | 121 | 192 | 5.3E-16 | T | 22-09-2020 | IPR001525 | C-5 cytosine methyltransferase |
| UnnamedSample_HQ_transcript/78648|m.19490 | UnnamedSample_HQ_transcript/78648 | Coverage 0.073 too low. | 845add26aeb06da8193c211086cec248 | 477 | Pfam | PF08662 | Eukaryotic translation initiation factor eIF2A | 213 | 408 | 3.7E-78 | T | 22-09-2020 | IPR013979 | Translation initiation factor, beta propellor-like domain |
| UnnamedSample_HQ_transcript/98240|m.22400 | UnnamedSample_HQ_transcript/98240 | Coverage 0.986 too low. | 656293302f555099d93fab0f53eb00a9 | 301 | Pfam | PF01798 | snoRNA binding domain, fibrillarin | 53 | 281 | 4.2E-81 | T | 22-09-2020 | IPR002687 | Nop domain |
| UnnamedSample_HQ_transcript/17414|m.6125 | UnnamedSample_HQ_transcript/17414 | Coverage 0.860 too low. | 528aab3ba69aaf4cb4a82cf5a98377f7 | 964 | Pfam | PF00047 | Immunoglobulin domain | 132 | 240 | 3.5E-6 | T | 22-09-2020 | IPR013151 | Immunoglobulin |
| UnnamedSample_HQ_transcript/17414|m.6125 | UnnamedSample_HQ_transcript/17414 | Coverage 0.860 too low. | 528aab3ba69aaf4cb4a82cf5a98377f7 | 964 | Pfam | PF07714 | Protein tyrosine and serine/threonine kinase | 542 | 863 | 4.5E-77 | T | 22-09-2020 | IPR001245 | Serine-threonine/tyrosine-protein kinase, catalytic domain |
| UnnamedSample_HQ_transcript/18761|m.6521 | UnnamedSample_HQ_transcript/18761 | Coverage 0.884 too low. | 528aab3ba69aaf4cb4a82cf5a98377f7 | 964 | Pfam | PF00047 | Immunoglobulin domain | 132 | 240 | 3.5E-6 | T | 22-09-2020 | IPR013151 | Immunoglobulin |
| UnnamedSample_HQ_transcript/18761|m.6521 | UnnamedSample_HQ_transcript/18761 | Coverage 0.884 too low. | 528aab3ba69aaf4cb4a82cf5a98377f7 | 964 | Pfam | PF07714 | Protein tyrosine and serine/threonine kinase | 542 | 863 | 4.5E-77 | T | 22-09-2020 | IPR001245 | Serine-threonine/tyrosine-protein kinase, catalytic domain |
| UnnamedSample_HQ_transcript/110461|m.23891 | UnnamedSample_HQ_transcript/110461 | Coverage 0.933 too low. | b3bfb3a4c615a427fb41ed5416067192 | 189 | Pfam | PF00210 | Ferritin-like domain | 14 | 164 | 1.2E-26 | T | 22-09-2020 | IPR008331 | Ferritin/DPS protein domain |
| UnnamedSample_HQ_transcript/18038|m.6312 | UnnamedSample_HQ_transcript/18038 | Coverage 0.062 too low. | d002c9a9d760374067c9cc3ea4c37e00 | 322 | Pfam | PF00027 | Cyclic nucleotide-binding domain | 205 | 287 | 3.1E-19 | T | 22-09-2020 | IPR000595 | Cyclic nucleotide-binding domain |
| UnnamedSample_HQ_transcript/97623|m.22317 | UnnamedSample_HQ_transcript/97623 | Coverage 0.372 too low. | 686c7251e6208375452524ac631c9034 | 246 | Pfam | PF00244 | 14-3-3 protein | 12 | 231 | 1.7E-109 | T | 22-09-2020 | IPR023410 | 14-3-3 domain |
| UnnamedSample_HQ_transcript/99266|m.22532 | UnnamedSample_HQ_transcript/99266 | Coverage 0.387 too low. | 686c7251e6208375452524ac631c9034 | 246 | Pfam | PF00244 | 14-3-3 protein | 12 | 231 | 1.7E-109 | T | 22-09-2020 | IPR023410 | 14-3-3 domain |
| UnnamedSample_HQ_transcript/103192|m.23013 | UnnamedSample_HQ_transcript/103192 | Coverage 0.413 too low. | 686c7251e6208375452524ac631c9034 | 246 | Pfam | PF00244 | 14-3-3 protein | 12 | 231 | 1.7E-109 | T | 22-09-2020 | IPR023410 | 14-3-3 domain |
| UnnamedSample_HQ_transcript/95192|m.21982 | UnnamedSample_HQ_transcript/95192 | Coverage 0.353 too low. | 686c7251e6208375452524ac631c9034 | 246 | Pfam | PF00244 | 14-3-3 protein | 12 | 231 | 1.7E-109 | T | 22-09-2020 | IPR023410 | 14-3-3 domain |
| UnnamedSample_HQ_transcript/110826|m.23942 | UnnamedSample_HQ_transcript/110826 | Coverage 0.498 too low. | 686c7251e6208375452524ac631c9034 | 246 | Pfam | PF00244 | 14-3-3 protein | 12 | 231 | 1.7E-109 | T | 22-09-2020 | IPR023410 | 14-3-3 domain |
| UnnamedSample_HQ_transcript/99085|m.22508 | UnnamedSample_HQ_transcript/99085 | Coverage 0.493 too low. | 686c7251e6208375452524ac631c9034 | 246 | Pfam | PF00244 | 14-3-3 protein | 12 | 231 | 1.7E-109 | T | 22-09-2020 | IPR023410 | 14-3-3 domain |
| UnnamedSample_HQ_transcript/92501|m.21599 | UnnamedSample_HQ_transcript/92501 | Coverage 0.418 too low. | 686c7251e6208375452524ac631c9034 | 246 | Pfam | PF00244 | 14-3-3 protein | 12 | 231 | 1.7E-109 | T | 22-09-2020 | IPR023410 | 14-3-3 domain |
| UnnamedSample_HQ_transcript/94124|m.21818 | UnnamedSample_HQ_transcript/94124 | Coverage 0.444 too low. | 686c7251e6208375452524ac631c9034 | 246 | Pfam | PF00244 | 14-3-3 protein | 12 | 231 | 1.7E-109 | T | 22-09-2020 | IPR023410 | 14-3-3 domain |
| UnnamedSample_HQ_transcript/104530|m.23171 | UnnamedSample_HQ_transcript/104530 | Coverage 0.444 too low. | 686c7251e6208375452524ac631c9034 | 246 | Pfam | PF00244 | 14-3-3 protein | 12 | 231 | 1.7E-109 | T | 22-09-2020 | IPR023410 | 14-3-3 domain |
| UnnamedSample_HQ_transcript/107332|m.23501 | UnnamedSample_HQ_transcript/107332 | Coverage 0.386 too low. | 686c7251e6208375452524ac631c9034 | 246 | Pfam | PF00244 | 14-3-3 protein | 12 | 231 | 1.7E-109 | T | 22-09-2020 | IPR023410 | 14-3-3 domain |
| UnnamedSample_HQ_transcript/90105|m.21271 | UnnamedSample_HQ_transcript/90105 | Coverage 0.401 too low. | 686c7251e6208375452524ac631c9034 | 246 | Pfam | PF00244 | 14-3-3 protein | 12 | 231 | 1.7E-109 | T | 22-09-2020 | IPR023410 | 14-3-3 domain |
| UnnamedSample_HQ_transcript/98402|m.22417 | UnnamedSample_HQ_transcript/98402 | Coverage 0.466 too low. | 686c7251e6208375452524ac631c9034 | 246 | Pfam | PF00244 | 14-3-3 protein | 12 | 231 | 1.7E-109 | T | 22-09-2020 | IPR023410 | 14-3-3 domain |
| UnnamedSample_HQ_transcript/18914|m.6556 | UnnamedSample_HQ_transcript/18914 | Coverage 0.139 too low. | 5d725b69d7b1eee967d2752808d1c236 | 923 | Pfam | PF00621 | RhoGEF domain | 318 | 498 | 7.0E-36 | T | 22-09-2020 | IPR000219 | Dbl homology (DH) domain |
| UnnamedSample_HQ_transcript/18914|m.6556 | UnnamedSample_HQ_transcript/18914 | Coverage 0.139 too low. | 5d725b69d7b1eee967d2752808d1c236 | 923 | Pfam | PF19057 | PH domain | 523 | 656 | 2.3E-38 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/18914|m.6556 | UnnamedSample_HQ_transcript/18914 | Coverage 0.139 too low. | 5d725b69d7b1eee967d2752808d1c236 | 923 | Pfam | PF19056 | WD40 repeated domain | 822 | 921 | 7.1E-10 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/49012|m.13801 | UnnamedSample_HQ_transcript/49012 | Coverage 0.132 too low. | f64ddc5368f27ad2cd62b79e930a2951 | 278 | Pfam | PF10160 | Predicted membrane protein | 8 | 193 | 3.3E-52 | T | 22-09-2020 | IPR018781 | Transmembrane protein TPRA1/CAND2/CAND8 |
| UnnamedSample_HQ_transcript/35919|m.10911 | UnnamedSample_HQ_transcript/35919 | Unmapped. | 4d066c9f80c2e233d50b5ae9f4fa4e66 | 864 | Pfam | PF00910 | RNA helicase | 379 | 487 | 2.6E-18 | T | 22-09-2020 | IPR000605 | Helicase, superfamily 3, single-stranded DNA/RNA virus |
| UnnamedSample_HQ_transcript/17546|m.6176 | UnnamedSample_HQ_transcript/17546 | Coverage 0.826 too low. | 728eb0854ea047c435bddc6204345928 | 431 | Pfam | PF00271 | Helicase conserved C-terminal domain | 340 | 418 | 2.9E-14 | T | 22-09-2020 | IPR001650 | Helicase, C-terminal |
| UnnamedSample_HQ_transcript/17546|m.6176 | UnnamedSample_HQ_transcript/17546 | Coverage 0.826 too low. | 728eb0854ea047c435bddc6204345928 | 431 | Pfam | PF00270 | DEAD/DEAH box helicase | 131 | 302 | 2.3E-48 | T | 22-09-2020 | IPR011545 | DEAD/DEAH box helicase domain |
| UnnamedSample_HQ_transcript/88485|m.21015 | UnnamedSample_HQ_transcript/88485 | Coverage 0.195 too low. | 9f15ce90fa84423d3a110cc0f4f80ec4 | 300 | Pfam | PF00650 | CRAL/TRIO domain | 94 | 239 | 2.3E-19 | T | 22-09-2020 | IPR001251 | CRAL-TRIO lipid binding domain |
| UnnamedSample_HQ_transcript/91849|m.21519 | UnnamedSample_HQ_transcript/91849 | Coverage 0.204 too low. | 9f15ce90fa84423d3a110cc0f4f80ec4 | 300 | Pfam | PF00650 | CRAL/TRIO domain | 94 | 239 | 2.3E-19 | T | 22-09-2020 | IPR001251 | CRAL-TRIO lipid binding domain |
| UnnamedSample_HQ_transcript/97412|m.22291 | UnnamedSample_HQ_transcript/97412 | Coverage 0.083 too low. | 9f15ce90fa84423d3a110cc0f4f80ec4 | 300 | Pfam | PF00650 | CRAL/TRIO domain | 94 | 239 | 2.3E-19 | T | 22-09-2020 | IPR001251 | CRAL-TRIO lipid binding domain |
| UnnamedSample_HQ_transcript/94742|m.21916 | UnnamedSample_HQ_transcript/94742 | Coverage 0.076 too low. | 9f15ce90fa84423d3a110cc0f4f80ec4 | 300 | Pfam | PF00650 | CRAL/TRIO domain | 94 | 239 | 2.3E-19 | T | 22-09-2020 | IPR001251 | CRAL-TRIO lipid binding domain |
| UnnamedSample_HQ_transcript/100975|m.22751 | UnnamedSample_HQ_transcript/100975 | Coverage 0.985 too low. | 9f15ce90fa84423d3a110cc0f4f80ec4 | 300 | Pfam | PF00650 | CRAL/TRIO domain | 94 | 239 | 2.3E-19 | T | 22-09-2020 | IPR001251 | CRAL-TRIO lipid binding domain |
| UnnamedSample_HQ_transcript/98505|m.22433 | UnnamedSample_HQ_transcript/98505 | Coverage 0.989 too low. | d3689d379165d4681d8275fec5968614 | 320 | Pfam | PF01873 | Domain found in IF2B/IF5 | 184 | 294 | 1.4E-40 | T | 22-09-2020 | IPR002735 | Translation initiation factor IF2/IF5 |
| UnnamedSample_HQ_transcript/17570|m.6183 | UnnamedSample_HQ_transcript/17570 | Coverage 0.558 too low. | b6d1b3e2992da5ec6c87c92699954fab | 313 | Pfam | PF04947 | Poxvirus Late Transcription Factor VLTF3 like | 155 | 310 | 2.4E-32 | T | 22-09-2020 | IPR007031 | Poxvirus VLTF3, late transcription factor |
| UnnamedSample_HQ_transcript/65399|m.17101 | UnnamedSample_HQ_transcript/65399 | Coverage 0.985 too low. | 651fc8137a4fb53ed03057387e2c6ee9 | 434 | Pfam | PF05221 | S-adenosyl-L-homocysteine hydrolase | 8 | 143 | 5.8E-74 | T | 22-09-2020 | IPR000043 | Adenosylhomocysteinase-like |
| UnnamedSample_HQ_transcript/65399|m.17101 | UnnamedSample_HQ_transcript/65399 | Coverage 0.985 too low. | 651fc8137a4fb53ed03057387e2c6ee9 | 434 | Pfam | PF00670 | S-adenosyl-L-homocysteine hydrolase, NAD binding domain | 193 | 354 | 4.2E-82 | T | 22-09-2020 | IPR015878 | S-adenosyl-L-homocysteine hydrolase, NAD binding domain |
| UnnamedSample_HQ_transcript/79339|m.19600 | UnnamedSample_HQ_transcript/79339 | Coverage 0.983 too low. | 651fc8137a4fb53ed03057387e2c6ee9 | 434 | Pfam | PF05221 | S-adenosyl-L-homocysteine hydrolase | 8 | 143 | 5.8E-74 | T | 22-09-2020 | IPR000043 | Adenosylhomocysteinase-like |
| UnnamedSample_HQ_transcript/79339|m.19600 | UnnamedSample_HQ_transcript/79339 | Coverage 0.983 too low. | 651fc8137a4fb53ed03057387e2c6ee9 | 434 | Pfam | PF00670 | S-adenosyl-L-homocysteine hydrolase, NAD binding domain | 193 | 354 | 4.2E-82 | T | 22-09-2020 | IPR015878 | S-adenosyl-L-homocysteine hydrolase, NAD binding domain |
| UnnamedSample_HQ_transcript/66297|m.17267 | UnnamedSample_HQ_transcript/66297 | Coverage 0.979 too low. | 651fc8137a4fb53ed03057387e2c6ee9 | 434 | Pfam | PF05221 | S-adenosyl-L-homocysteine hydrolase | 8 | 143 | 5.8E-74 | T | 22-09-2020 | IPR000043 | Adenosylhomocysteinase-like |
| UnnamedSample_HQ_transcript/66297|m.17267 | UnnamedSample_HQ_transcript/66297 | Coverage 0.979 too low. | 651fc8137a4fb53ed03057387e2c6ee9 | 434 | Pfam | PF00670 | S-adenosyl-L-homocysteine hydrolase, NAD binding domain | 193 | 354 | 4.2E-82 | T | 22-09-2020 | IPR015878 | S-adenosyl-L-homocysteine hydrolase, NAD binding domain |
| UnnamedSample_HQ_transcript/66594|m.17332 | UnnamedSample_HQ_transcript/66594 | Coverage 0.985 too low. | 651fc8137a4fb53ed03057387e2c6ee9 | 434 | Pfam | PF05221 | S-adenosyl-L-homocysteine hydrolase | 8 | 143 | 5.8E-74 | T | 22-09-2020 | IPR000043 | Adenosylhomocysteinase-like |
| UnnamedSample_HQ_transcript/66594|m.17332 | UnnamedSample_HQ_transcript/66594 | Coverage 0.985 too low. | 651fc8137a4fb53ed03057387e2c6ee9 | 434 | Pfam | PF00670 | S-adenosyl-L-homocysteine hydrolase, NAD binding domain | 193 | 354 | 4.2E-82 | T | 22-09-2020 | IPR015878 | S-adenosyl-L-homocysteine hydrolase, NAD binding domain |
| UnnamedSample_HQ_transcript/40699|m.12009 | UnnamedSample_HQ_transcript/40699 | Coverage 0.841 too low. | f5c37bd765a76d2d9df999ed0f498a51 | 508 | Pfam | PF00083 | Sugar (and other) transporter | 31 | 468 | 4.6E-88 | T | 22-09-2020 | IPR005828 | Major facilitator, sugar transporter-like |
| UnnamedSample_HQ_transcript/2210|m.1135 | UnnamedSample_HQ_transcript/2210 | Coverage 0.931 too low. | f5c37bd765a76d2d9df999ed0f498a51 | 508 | Pfam | PF00083 | Sugar (and other) transporter | 31 | 468 | 4.6E-88 | T | 22-09-2020 | IPR005828 | Major facilitator, sugar transporter-like |
| UnnamedSample_HQ_transcript/2401|m.1200 | UnnamedSample_HQ_transcript/2401 | Coverage 0.963 too low. | f5c37bd765a76d2d9df999ed0f498a51 | 508 | Pfam | PF00083 | Sugar (and other) transporter | 31 | 468 | 4.6E-88 | T | 22-09-2020 | IPR005828 | Major facilitator, sugar transporter-like |
| UnnamedSample_HQ_transcript/2005|m.1057 | UnnamedSample_HQ_transcript/2005 | Coverage 0.932 too low. | f5c37bd765a76d2d9df999ed0f498a51 | 508 | Pfam | PF00083 | Sugar (and other) transporter | 31 | 468 | 4.6E-88 | T | 22-09-2020 | IPR005828 | Major facilitator, sugar transporter-like |
| UnnamedSample_HQ_transcript/88838|m.21060 | UnnamedSample_HQ_transcript/88838 | Coverage 0.772 too low. | 6f4e20815b51d2563e0956b0e5d0924c | 413 | Pfam | PF07766 | LETM1-like protein | 1 | 198 | 2.1E-71 | T | 22-09-2020 | IPR011685 | LETM1-like |
| UnnamedSample_HQ_transcript/84635|m.20439 | UnnamedSample_HQ_transcript/84635 | Coverage 0.732 too low. | 6f4e20815b51d2563e0956b0e5d0924c | 413 | Pfam | PF07766 | LETM1-like protein | 1 | 198 | 2.1E-71 | T | 22-09-2020 | IPR011685 | LETM1-like |
| UnnamedSample_HQ_transcript/79634|m.19647 | UnnamedSample_HQ_transcript/79634 | Coverage 0.665 too low. | 6f4e20815b51d2563e0956b0e5d0924c | 413 | Pfam | PF07766 | LETM1-like protein | 1 | 198 | 2.1E-71 | T | 22-09-2020 | IPR011685 | LETM1-like |
| UnnamedSample_HQ_transcript/2441|m.1216 | UnnamedSample_HQ_transcript/2441 | Unmapped. | 97da1821cf8f8c53809dc02b6d824953 | 1509 | Pfam | PF00680 | Viral RNA-dependent RNA polymerase | 491 | 859 | 2.5E-9 | T | 22-09-2020 | IPR001205 | RNA-directed RNA polymerase, C-terminal domain |
| UnnamedSample_HQ_transcript/2441|m.1216 | UnnamedSample_HQ_transcript/2441 | Unmapped. | 97da1821cf8f8c53809dc02b6d824953 | 1509 | Pfam | PF13086 | AAA domain | 1260 | 1330 | 7.3E-9 | T | 22-09-2020 | IPR041677 | DNA2/NAM7 helicase, helicase domain |
| UnnamedSample_HQ_transcript/1901|m.1018 | UnnamedSample_HQ_transcript/1901 | Unmapped. | 97da1821cf8f8c53809dc02b6d824953 | 1509 | Pfam | PF00680 | Viral RNA-dependent RNA polymerase | 491 | 859 | 2.5E-9 | T | 22-09-2020 | IPR001205 | RNA-directed RNA polymerase, C-terminal domain |
| UnnamedSample_HQ_transcript/1901|m.1018 | UnnamedSample_HQ_transcript/1901 | Unmapped. | 97da1821cf8f8c53809dc02b6d824953 | 1509 | Pfam | PF13086 | AAA domain | 1260 | 1330 | 7.3E-9 | T | 22-09-2020 | IPR041677 | DNA2/NAM7 helicase, helicase domain |
| UnnamedSample_HQ_transcript/2469|m.1224 | UnnamedSample_HQ_transcript/2469 | Coverage 0.985 too low. | 80b3ece9d6ce1e779f7048f043ff2b97 | 551 | Pfam | PF00498 | FHA domain | 19 | 85 | 2.3E-11 | T | 22-09-2020 | IPR000253 | Forkhead-associated (FHA) domain |
| UnnamedSample_HQ_transcript/57037|m.15456 | UnnamedSample_HQ_transcript/57037 | Coverage 0.479 too low. | 9bc8775c7aaa58ce51aa3cf47d789ffb | 610 | Pfam | PF07766 | LETM1-like protein | 146 | 410 | 4.1E-103 | T | 22-09-2020 | IPR011685 | LETM1-like |
| UnnamedSample_HQ_transcript/1536|m.869 | UnnamedSample_HQ_transcript/1536 | Coverage 0.184 too low. | d01654ad87e7e3b070441e47221164f1 | 533 | Pfam | PF16212 | Phospholipid-translocating P-type ATPase C-terminal | 430 | 531 | 8.6E-45 | T | 22-09-2020 | IPR032630 | P-type ATPase, C-terminal |
| UnnamedSample_HQ_transcript/1536|m.869 | UnnamedSample_HQ_transcript/1536 | Coverage 0.184 too low. | d01654ad87e7e3b070441e47221164f1 | 533 | Pfam | PF13246 | Cation transport ATPase (P-type) | 93 | 183 | 1.3E-12 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/50811|m.14206 | UnnamedSample_HQ_transcript/50811 | Unmapped. | e8d1ddb4e1b0b007f34a896a52ae2ecc | 709 | Pfam | PF08762 | CRPV capsid protein like | 411 | 621 | 2.3E-12 | T | 22-09-2020 | IPR014872 | Dicistrovirus, capsid-polyprotein, C-terminal |
| UnnamedSample_HQ_transcript/50211|m.14063 | UnnamedSample_HQ_transcript/50211 | Coverage 0.987 too low. | 023fa3ac7728c2cb13c990101d47c308 | 586 | Pfam | PF00364 | Biotin-requiring enzyme | 165 | 237 | 2.6E-18 | T | 22-09-2020 | IPR000089 | Biotin/lipoyl attachment |
| UnnamedSample_HQ_transcript/50211|m.14063 | UnnamedSample_HQ_transcript/50211 | Coverage 0.987 too low. | 023fa3ac7728c2cb13c990101d47c308 | 586 | Pfam | PF00364 | Biotin-requiring enzyme | 50 | 122 | 2.1E-17 | T | 22-09-2020 | IPR000089 | Biotin/lipoyl attachment |
| UnnamedSample_HQ_transcript/50211|m.14063 | UnnamedSample_HQ_transcript/50211 | Coverage 0.987 too low. | 023fa3ac7728c2cb13c990101d47c308 | 586 | Pfam | PF00198 | 2-oxoacid dehydrogenases acyltransferase (catalytic domain) | 355 | 574 | 2.0E-70 | T | 22-09-2020 | IPR001078 | 2-oxoacid dehydrogenase acyltransferase, catalytic domain |
| UnnamedSample_HQ_transcript/36687|m.11092 | UnnamedSample_HQ_transcript/36687 | Coverage 0.444 too low. | 067709598675443d65714b5c5824bf00 | 446 | Pfam | PF13632 | Glycosyl transferase family group 2 | 171 | 371 | 4.9E-37 | T | 22-09-2020 | IPR001173 | Glycosyltransferase 2-like |
| UnnamedSample_HQ_transcript/51596|m.14372 | UnnamedSample_HQ_transcript/51596 | Coverage 0.620 too low. | 067709598675443d65714b5c5824bf00 | 446 | Pfam | PF13632 | Glycosyl transferase family group 2 | 171 | 371 | 4.9E-37 | T | 22-09-2020 | IPR001173 | Glycosyltransferase 2-like |
| UnnamedSample_HQ_transcript/77128|m.19224 | UnnamedSample_HQ_transcript/77128 | Coverage 0.194 too low. | 69646e7285f05a08d9d8e00a024fa592 | 318 | Pfam | PF00096 | Zinc finger, C2H2 type | 287 | 310 | 4.5E-6 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/3094|m.1477 | UnnamedSample_HQ_transcript/3094 | Unmapped. | 960b7913033ed85ec1806a637cf3fad4 | 909 | Pfam | PF00910 | RNA helicase | 222 | 330 | 2.8E-18 | T | 22-09-2020 | IPR000605 | Helicase, superfamily 3, single-stranded DNA/RNA virus |
| UnnamedSample_HQ_transcript/63605|m.16757 | UnnamedSample_HQ_transcript/63605 | Coverage 0.902 too low. | a86f6b22673ab429b2dfa187bf91972c | 511 | Pfam | PF13855 | Leucine rich repeat | 48 | 89 | 8.2E-7 | T | 22-09-2020 | IPR001611 | Leucine-rich repeat |
| UnnamedSample_HQ_transcript/63605|m.16757 | UnnamedSample_HQ_transcript/63605 | Coverage 0.902 too low. | a86f6b22673ab429b2dfa187bf91972c | 511 | Pfam | PF13855 | Leucine rich repeat | 99 | 135 | 1.5E-6 | T | 22-09-2020 | IPR001611 | Leucine-rich repeat |
| UnnamedSample_HQ_transcript/63605|m.16757 | UnnamedSample_HQ_transcript/63605 | Coverage 0.902 too low. | a86f6b22673ab429b2dfa187bf91972c | 511 | Pfam | PF00626 | Gelsolin repeat | 347 | 424 | 2.4E-14 | T | 22-09-2020 | IPR007123 | Gelsolin-like domain |
| UnnamedSample_HQ_transcript/73710|m.18599 | UnnamedSample_HQ_transcript/73710 | Coverage 0.887 too low. | a86f6b22673ab429b2dfa187bf91972c | 511 | Pfam | PF13855 | Leucine rich repeat | 48 | 89 | 8.2E-7 | T | 22-09-2020 | IPR001611 | Leucine-rich repeat |
| UnnamedSample_HQ_transcript/73710|m.18599 | UnnamedSample_HQ_transcript/73710 | Coverage 0.887 too low. | a86f6b22673ab429b2dfa187bf91972c | 511 | Pfam | PF13855 | Leucine rich repeat | 99 | 135 | 1.5E-6 | T | 22-09-2020 | IPR001611 | Leucine-rich repeat |
| UnnamedSample_HQ_transcript/73710|m.18599 | UnnamedSample_HQ_transcript/73710 | Coverage 0.887 too low. | a86f6b22673ab429b2dfa187bf91972c | 511 | Pfam | PF00626 | Gelsolin repeat | 347 | 424 | 2.4E-14 | T | 22-09-2020 | IPR007123 | Gelsolin-like domain |
| UnnamedSample_HQ_transcript/26158|m.8518 | UnnamedSample_HQ_transcript/26158 | Coverage 0.666 too low. | e86af227d1f6aa5bbcaf5a479011cef8 | 523 | Pfam | PF01754 | A20-like zinc finger | 495 | 517 | 1.8E-7 | T | 22-09-2020 | IPR002653 | Zinc finger, A20-type |
| UnnamedSample_HQ_transcript/26158|m.8518 | UnnamedSample_HQ_transcript/26158 | Coverage 0.666 too low. | e86af227d1f6aa5bbcaf5a479011cef8 | 523 | Pfam | PF02338 | OTU-like cysteine protease | 126 | 293 | 8.5E-22 | T | 22-09-2020 | IPR003323 | OTU domain |
| UnnamedSample_HQ_transcript/2010|m.1061 | UnnamedSample_HQ_transcript/2010 | Coverage 0.315 too low. | 70cb4cc3be2c3e3f1bba51aafad8737e | 1339 | Pfam | PF00439 | Bromodomain | 343 | 423 | 5.7E-15 | T | 22-09-2020 | IPR001487 | Bromodomain |
| UnnamedSample_HQ_transcript/104306|m.23146 | UnnamedSample_HQ_transcript/104306 | Coverage 0.988 too low. | 2dbf309f54d19cd08e4ba3a1dcc7af68 | 291 | Pfam | PF00397 | WW domain | 167 | 194 | 9.6E-10 | T | 22-09-2020 | IPR001202 | WW domain |
| UnnamedSample_HQ_transcript/104306|m.23146 | UnnamedSample_HQ_transcript/104306 | Coverage 0.988 too low. | 2dbf309f54d19cd08e4ba3a1dcc7af68 | 291 | Pfam | PF00397 | WW domain | 126 | 153 | 1.5E-10 | T | 22-09-2020 | IPR001202 | WW domain |
| UnnamedSample_HQ_transcript/2030|m.1070 | UnnamedSample_HQ_transcript/2030 | Identity 0.910 too low. | 341515875a3a69fc9d4e0d79ef7896b1 | 630 | Pfam | PF00651 | BTB/POZ domain | 22 | 118 | 2.6E-24 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/10418|m.3963 | UnnamedSample_HQ_transcript/10418 | Coverage 0.985 too low. | 6b57075682aa552f97e629c7bfc4aa87 | 1137 | Pfam | PF14750 | Integrator complex subunit 2 | 20 | 1080 | 0 | T | 22-09-2020 | IPR029321 | Integrator complex subunit 2 |
| UnnamedSample_HQ_transcript/117273|m.24618 | UnnamedSample_HQ_transcript/117273 | Coverage 0.989 too low. | ba2dda9b665527cba86ba73c8e659583 | 223 | Pfam | PF01798 | snoRNA binding domain, fibrillarin | 2 | 157 | 1.9E-57 | T | 22-09-2020 | IPR002687 | Nop domain |
| UnnamedSample_HQ_transcript/23132|m.7721 | UnnamedSample_HQ_transcript/23132 | Coverage 0.961 too low. | cbc1d10917c27947595c8032091cfae8 | 939 | Pfam | PF13927 | Immunoglobulin domain | 636 | 716 | 1.3E-9 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/23132|m.7721 | UnnamedSample_HQ_transcript/23132 | Coverage 0.961 too low. | cbc1d10917c27947595c8032091cfae8 | 939 | Pfam | PF00041 | Fibronectin type III domain | 849 | 910 | 1.3E-5 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/18718|m.6506 | UnnamedSample_HQ_transcript/18718 | Identity 0.770 too low. | cbc1d10917c27947595c8032091cfae8 | 939 | Pfam | PF13927 | Immunoglobulin domain | 636 | 716 | 1.3E-9 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/18718|m.6506 | UnnamedSample_HQ_transcript/18718 | Identity 0.770 too low. | cbc1d10917c27947595c8032091cfae8 | 939 | Pfam | PF00041 | Fibronectin type III domain | 849 | 910 | 1.3E-5 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/16302|m.5794 | UnnamedSample_HQ_transcript/16302 | Identity 0.778 too low. | cbc1d10917c27947595c8032091cfae8 | 939 | Pfam | PF13927 | Immunoglobulin domain | 636 | 716 | 1.3E-9 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/16302|m.5794 | UnnamedSample_HQ_transcript/16302 | Identity 0.778 too low. | cbc1d10917c27947595c8032091cfae8 | 939 | Pfam | PF00041 | Fibronectin type III domain | 849 | 910 | 1.3E-5 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/71360|m.18182 | UnnamedSample_HQ_transcript/71360 | Coverage 0.728 too low. | 925b4d05480d403c0c45dc497f56c8cc | 557 | Pfam | PF11732 | Transcription- and export-related complex subunit | 446 | 521 | 4.2E-24 | T | 22-09-2020 | IPR021726 | THO complex, subunitTHOC2, N-terminal |
| UnnamedSample_HQ_transcript/71360|m.18182 | UnnamedSample_HQ_transcript/71360 | Coverage 0.728 too low. | 925b4d05480d403c0c45dc497f56c8cc | 557 | Pfam | PF16134 | THO complex subunit 2 N-terminus | 2 | 283 | 1.3E-46 | T | 22-09-2020 | IPR032302 | THO complex subunit 2, N-terminal domain |
| UnnamedSample_HQ_transcript/71360|m.18182 | UnnamedSample_HQ_transcript/71360 | Coverage 0.728 too low. | 925b4d05480d403c0c45dc497f56c8cc | 557 | Pfam | PF16134 | THO complex subunit 2 N-terminus | 310 | 444 | 4.2E-22 | T | 22-09-2020 | IPR032302 | THO complex subunit 2, N-terminal domain |
| UnnamedSample_HQ_transcript/28586|m.9111 | UnnamedSample_HQ_transcript/28586 | Coverage 0.061 too low. | 24c89df0589229318fd9ca490b9afa5a | 713 | Pfam | PF01061 | ABC-2 type transporter | 422 | 631 | 1.4E-22 | T | 22-09-2020 | IPR013525 | ABC-2 type transporter |
| UnnamedSample_HQ_transcript/28586|m.9111 | UnnamedSample_HQ_transcript/28586 | Coverage 0.061 too low. | 24c89df0589229318fd9ca490b9afa5a | 713 | Pfam | PF19055 | ABC-2 type transporter | 299 | 355 | 6.4E-6 | T | 22-09-2020 | IPR043926 | ABC transporter family G domain |
| UnnamedSample_HQ_transcript/28586|m.9111 | UnnamedSample_HQ_transcript/28586 | Coverage 0.061 too low. | 24c89df0589229318fd9ca490b9afa5a | 713 | Pfam | PF00005 | ABC transporter | 124 | 270 | 8.5E-26 | T | 22-09-2020 | IPR003439 | ABC transporter-like |
| UnnamedSample_HQ_transcript/27330|m.8797 | UnnamedSample_HQ_transcript/27330 | Coverage 0.060 too low. | 24c89df0589229318fd9ca490b9afa5a | 713 | Pfam | PF01061 | ABC-2 type transporter | 422 | 631 | 1.4E-22 | T | 22-09-2020 | IPR013525 | ABC-2 type transporter |
A
B
C
D
E
F
G
H
I
J
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| 1. Protein accession (e.g. P51587) | |||||||||
| 2. Sequence MD5 digest (e.g. 14086411a2cdf1c4cba63020e1622579) | |||||||||
| 3. Sequence length (e.g. 3418) | |||||||||
| 4. Analysis (e.g. Pfam / PRINTS / Gene3D) | |||||||||
| 5. Signature accession (e.g. PF09103 / G3DSA:2.40.50.140) | |||||||||
| 6. Signature description (e.g. BRCA2 repeat profile) | |||||||||
| 7. Start location | |||||||||
| 8. Stop location | |||||||||
| 9. Score - is the e-value (or score) of the match reported by member database method (e.g. 3.1E-52) | |||||||||
| 10. Status - is the status of the match (T: true) | |||||||||
| 11. Date - is the date of the run | |||||||||
| 12. (InterPro annotations - accession (e.g. IPR002093) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
| 13. (InterPro annotations - description (e.g. BRCA2 repeat) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
